Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.98
-0.36 (-4.90%)
Aug 11, 2026, 4:00 PM EDT - Market closed
Profound Medical Revenue
Profound Medical had revenue of $5.34M in the quarter ending March 31, 2026, with 103.62% growth. This brings the company's revenue in the last twelve months to $18.81M, up 58.61% year-over-year. In the year 2025, Profound Medical had annual revenue of $16.10M with 50.73% growth.
Revenue (ttm)
$18.81M
Revenue Growth
+58.61%
P/S Ratio
13.38
Revenue / Employee
$117,815
Employees
162
Market Cap
255.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.10M | 5.42M | 50.73% |
| Dec 31, 2024 | 10.68M | 3.48M | 48.35% |
| Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
| Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
| Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
| Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
| Dec 31, 2019 | 4.17M | 2.26M | 117.58% |
| Dec 31, 2018 | 1.92M | -1.98M | -50.81% |
| Dec 31, 2017 | 3.90M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Treace Medical Concepts | 205.31M |
| Pacific Biosciences of California | 159.27M |
| InfuSystem Holdings | 143.34M |
| RxSight | 127.58M |
| Standard BioTools | 84.60M |
| AVITA Medical | 75.63M |
| Electromed | 71.75M |
| 908 Devices | 57.80M |
PROF News
- 5 days ago - Profound Medical Q2 Earnings Call Highlights - MarketBeat
- 5 days ago - Profound Medical (PROF) Q2 Earnings Surpass Estimates - Nasdaq
- 5 days ago - Is Profound Medical Corp (PROF) Positioned for Growth After Q2 Earnings Miss? GF Score: 74/100, ... - GuruFocus
- 5 days ago - Profound Medical Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Profound Medical Earnings release: Q2 2026 - Filings
- 5 days ago - Profound Medical Quarterly report: Q2 2026 - Filings
- 5 days ago - Profound Medical Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 6 days ago - Earnings To Watch: Profound Medical Corp (PROF) Q2 2026 -- GF Value Sees 226% Upside - GuruFocus